Cipla, GSK Battle It Out In Indian Respiratory Space
This article was originally published in PharmAsia News
Executive Summary
Competition in the fast-growing Indian respiratory market looks set to intensify with key players and traditional rivals, Cipla and GlaxoSmithKline, each outlining distinct new initiatives in the segment, where pricing is a key consideration.